Trending

Momenta

J&J pays $6.5bn for Momenta and its inflammatory disease hopeful

J&J pays $6.5bn for Momenta and its inflammatory disease hopeful

Johnson & Johnson is to buy Momenta Pharmaceuticals for $6.5 billion, adding potential inflammatory diseases blockbuster nipocalimab to

X

J&J pays $6.5bn for Momenta and its inflammatory disease hopeful

https://pharmaphorum.com/news/jj-pays-6-5bn-for-momenta-and-its-inflammatory-disease-hopeful/

Momenta rises thanks to its Copaxone challenger

Momenta rises thanks to its Copaxone challenger

Company is ready to launch three-times-weekly version of Teva’s drug

X

Momenta rises thanks to its Copaxone challenger

https://pharmaphorum.com/news/momenta-rises-thanks-copaxone-challenger/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com